Free-cash-flow proxy decreased 125.1%
Free-cash-flow proxy changed -125.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed -125.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed -119.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -171.1% from the comparable as-filed period.
Research & development changed +144.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed +84.8% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
Gross profit changed -41.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed +63.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +99.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed +127.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Noncurrent long-term debt changed -35.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed +2337 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +160.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed -1101.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base. This reverses 3 consecutive comparable moves in the opposite direction.
Cost of revenue changed -28.6% from the comparable as-filed period.
Trade receivables changed -47.7% from the comparable as-filed period.
Capital expenditure changed +1371.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Stock-based compensation changed +23.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current liabilities changed -12.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed -1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.